Zepbound 15 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9R0F
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,793
Award facts
- Contract value 100% obligated
- $17,793.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $17,793.48 to AmerisourceBergen Drug Corp for the supply of Zepbound 15 mg/0.5 mL pens on January 15, 2026, with an ultimate completion date of January 16, 2026. This firm fixed-price, non-set-aside contract was fulfilled from the contractor's place of performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc., which holds a substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999.99 million through December 31, 2031, serving as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
This contract represents a single task order for a diabetes medication within the broader context of Cencora's extensive federal pharmaceutical supply portfolio. As a major pharmaceutical distributor and critical vendor for military and veteran healthcare systems, Cencora and its subsidiary AmerisourceBergen compete on a full and open basis for federal medical procurement needs. The parent IDC encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains, enabling efficient fulfillment of pharmaceutical requirements for military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide.
Quick answers
Who was awarded contract SPE2DR26F9R0F?
SPE2DR26F9R0F was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F9R0F worth?
The government has obligated $17,793 on SPE2DR26F9R0F.
Is contract SPE2DR26F9R0F an order under another contract?
Yes. SPE2DR26F9R0F is a delivery order under SPE2DR25D3020, an indefinite delivery contract.
Was contract SPE2DR26F9R0F competed?
The extent of competition for SPE2DR26F9R0F was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award